Rashidul Haque and Sultana Rajia (2023) “AMP-kinase is the Main Target of Metformin in Regulating Type 2 Diabetes”, Research Highlights in Disease and Health Research Vol. 2, pp. 83–95. doi: 10.9734/bpi/rhdhr/v2/9366F.